Post by
MCA2009 on Dec 21, 2009 6:32pm
What has Changed?
Can anyone fill me in on what has changed in the short/medium/long term outlook with MDG.
As I see it, we were all expecting good results from this round of testing and those were delivered. There are still agreements on the table which were dependent on this and the Phase II study. Those are still in place and closer to being realized. Phase II is still scheduled to go ahead. Costs for vaccines with this technology are low and the speed at which they can be made are faster than traditional. Apart taking a beating from those who were ready to sell today regardless of news, it seems we are in a stronger position.
Anyone want to chime in on why we are worse off now?
TIA
MCA